![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 45, 46464-46473, November 5, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
The µ opioid receptor (MOR) is expressed in the central nervous system and specific cell lines with varying expression levels perhaps playing important roles. One of the neuronal-specific transcription regulators, neuron-restrictive silencer factor (NRSF), has been shown to repress the expression of neuron-specific genes in non-neuronal cells. However, we showed here that the neuron-restrictive silencer element (NRSE) of MOR functions as a critical regulator to repress the MOR gene expression in specific neuronal cells depending on NRSF expression level. Using co-transfection studies, we showed that the NRSE of the MOR promoter is functional in NRSF-positive cells (NS20Y and HeLa) but not in NRSF-negative cells (PC12). NRSF binds to the NRSE of the MOR gene in a sequence-specific manner confirmed by supershift and chromatin immunoprecipitation assays, respectively. The suppression of NRSF activity with either trichostatin A or a dominant-negative NRSF induced MOR promoter activity and transcription of the MOR gene. When the NRSF was disrupted in NS20Y and HeLa cells using small interfering RNA, the transcription of the endogenous target MOR gene increased significantly. This provides direct evidence the role of NRSF in the cells and also indicates that NRSF expression is regulated by post-translational modification in neuronal NMB cells. Our data suggested that NRSF can function as a repressor of MOR transcription in specific cells, via a mechanism dependent on the MOR NRSE.
Received for publication, April 1, 2004 , and in revised form, August 9, 2004.
* This work was supported by National Institutes of Health Research Grants DA00564, DA01583, DA11806, K05-DA70554, DA11190, and DA13926 and by the A&F Stark Fund of the Minnesota Medical Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pharmacology, University of Minnesota Medical School, 6-120 Jackson Hall, 321 Church St. S.E., Minneapolis, MN 55455. Tel.: 612-626-6539; Fax: 612-625-8408; E-mail: kimxx313{at}umn.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. S. Choi, K. Y. Song, C. K. Hwang, C. S. Kim, P.-Y. Law, L.-N. Wei, and H. H. Loh A Proteomics Approach for Identification of Single Strand DNA-binding Proteins Involved in Transcriptional Regulation of Mouse {micro} Opioid Receptor Gene Mol. Cell. Proteomics, August 1, 2008; 7(8): 1517 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Donev, L. C. Gray, B. Sivasankar, T. R. Hughes, C. W. van den Berg, and B. P. Morgan Modulation of CD59 Expression by Restrictive Silencer Factor-Derived Peptides in Cancer Immunotherapy for Neuroblastoma Cancer Res., July 15, 2008; 68(14): 5979 - 5987. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Choi, C. S. Kim, C. K. Hwang, K. Y. Song, P.-Y. Law, L.-N. Wei, and H. H. Loh Novel function of the poly(C)-binding protein {alpha}CP3 as a transcriptional repressor of the mu opioid receptor gene FASEB J, December 1, 2007; 21(14): 3963 - 3973. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Hwang, K. Y. Song, C. S. Kim, H. S. Choi, X.-H. Guo, P.-Y. Law, L.-N. Wei, and H. H. Loh Evidence of Endogenous Mu Opioid Receptor Regulation by Epigenetic Control of the Promoters Mol. Cell. Biol., July 1, 2007; 27(13): 4720 - 4736. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Song, C. K. Hwang, C. S. Kim, H. S. Choi, P.-Y. Law, L.-N. Wei, and H. H. Loh Translational repression of mouse mu opioid receptor expression via leaky scanning Nucleic Acids Res., March 12, 2007; 35(5): 1501 - 1513. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Formisano, K.-M. Noh, T. Miyawaki, T. Mashiko, M. V. L. Bennett, and R. S. Zukin Ischemic insults promote epigenetic reprogramming of {micro} opioid receptor expression in hippocampal neurons PNAS, March 6, 2007; 104(10): 4170 - 4175. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Kim, H. S. Choi, C. K. Hwang, K. Y. Song, B.-K. Lee, P.-Y. Law, L.-N. Wei, and H. H. Loh Evidence of the neuron-restrictive silencer factor (NRSF) interaction with Sp3 and its synergic repression to the mu opioid receptor (MOR) gene Nucleic Acids Res., December 2, 2006; 34(22): 6392 - 6403. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-P. Tsai, J. Bi, H. H. Loh, and L.-N. Wei Netrin-1 signaling regulates de novo protein synthesis of kappa opioid receptor by facilitating polysomal partition of its mRNA. J. Neurosci., September 20, 2006; 26(38): 9743 - 9749. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-S. Kim, K. K. Pandey, H. S. Choi, S.-Y. Kim, P.-Y. Law, L.-N. Wei, and H. H. Loh Poly(C) Binding Protein Family Is a Transcription Factor in {micro}-Opioid Receptor Gene Expression Mol. Pharmacol., September 1, 2005; 68(3): 729 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wu, C. K. Hwang, S. Yao, P.-Y. Law, H. H. Loh, and L.-N. Wei A Major Species of Mouse {micro}-opioid Receptor mRNA and Its Promoter-Dependent Functional Polyadenylation Signal Mol. Pharmacol., August 1, 2005; 68(2): 279 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Marinova, V. Vukojevic, S. Surcheva, T. Yakovleva, G. Cebers, N. Pasikova, I. Usynin, L. Hugonin, W. Fang, M. Hallberg, et al. Translocation of Dynorphin Neuropeptides across the Plasma Membrane: A PUTATIVE MECHANISM OF SIGNAL TRANSMISSION J. Biol. Chem., July 15, 2005; 280(28): 26360 - 26370. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |